Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (DRKS00041527) titled 'Prognostic Value of Tau-SAA as a Biomarker for the Diagnosis of Alzheimer's Disease' on Sept. 8.
Study Type: observational
Study Design:
Allocation:
Masking:
Control:
Assignment:
Study design purpose: diagnostic
Primary Sponsor: SeNostic GmbH
Condition:
G30.9
Alzheimer disease, unspecified
Intervention:
Group 1: This single-arm, prospective, purely observational, clinical correlation study aims to investigate the correlation between tau-SAA and the severity of Alzheimer's symptoms. To this end, serum tau-SAA and plasma p-tau217 levels will be measured in patients with a diagnosis of Alzheimer's disease who ha...